Source: VAERS.HHS.GOV
VAERS accepts reports of adverse events and reactions that occur following vaccination. Healthcare providers, vaccine manufacturers, and the public can submit reports to the system. While very important in monitoring vaccine safety, VAERS reports alone cannot be used to determine if a vaccine caused or contributed to an adverse event or illness. The reports may contain information that is incomplete, inaccurate, coincidental, or unverifiable. In large part, reports to VAERS are voluntary, which means they are subject to biases. This creates specific limitations on how the data can be used scientifically. Data from VAERS reports should always be interpreted with these limitations in mind.
The strengths of VAERS are that it is national in scope and can quickly provide an early warning of a safety problem with a vaccine. As part of CDC and FDA’s multi-system approach to post-licensure vaccine safety monitoring, VAERS is designed to rapidly detect unusual or unexpected patterns of adverse events, also known as “safety signals.” If a safety signal is found in VAERS, further studies can be done in safety systems such as the CDC’s Vaccine Safety Datalink (VSD) or the Clinical Immunization Safety Assessment (CISA) project. These systems do not have the same scientific limitations as VAERS, and can better assess health risks and possible connections between adverse events and a vaccine.
Key considerations and limitations of VAERS data:
VAERS data available to the public include only the initial report data to VAERS. Updated data which contains data from medical records and corrections reported during follow up are used by the government for analysis. However, for numerous reasons including data consistency, these amended data are not available to the public.
Thurs, Nov 4 2:45pm first vaccine dose. Only minor arm discomfort for Thursday and Friday. Some fatigue on Saturday and Sunday. By Monday afternoon, November 8 she started having unexplained high blood sugar reading (via cgm). This continues for three full days so far and caused her to miss one day of online school. It is if there is massive insulin resistance -- that we giver her insulin to cover meals but the insulin does not act how it normally does (we switched pods and insulin bottles to ensure it was not an equipment issue). She is 10 and has some puberty hormonal bg swings but we have not seen anything like this. The insulin, though supposed to start to take effect in 15 minutes is taking many hours. By then we have over corrected and then she crashes low. In comparison to previous weeks, she is far above her average time in range, average bg number and standard deviation with 176bg, 51% in range , 10% very high and 60 SD. The week before in comparison was 150bg, 65% in rance, 1% very high and 42SD. These numbers do not show the immense fear and exhaustion that this has caused. We just want people to be aware that for Type 1 kids there may be a delayed amount of bg highs and lows due to increased insulin resistance. As T1D parents we always expect bg swings with any medicine or vaccine but this has been very different and social media searches indicate this is happening to others though overlooked and underreported as this is considered a 'normal' response. But the severity needs to be noted. My kiddo should never be 400+ after eating anything if she has insulin on board. It is very scary and just want someone to know. We hope this wears off soon. Thank you.
Open in Wayback Machine
(If this is a foreign report without a description you will be able to read the description in the Wayback Machine on Medalerts if the report became public for the first time before November 18, 2022.)
| Name | Dose # | Type | Manufacturer | Lot | Route | Site |
|---|---|---|---|---|---|---|
| COVID19 (COVID19 (PFIZER-BIONTECH)) | 1 | COVID19 | PFIZER\BIONTECH | FK5127 | IM | LA |
| RECVDATE: | 11-12-2021 | RPT_DATE: |
| CAGE_YR: | 10 |
| CAGE_MO: | |
| DIED: | U |
| DATEDIED: | |
| L_THREAT: | U |
| ER_VISIT: | |
| HOSPITAL: | U |
| HOSPDAYS: | |
| X_STAY: | U |
| DISABLE: | U |
| RECOVD: | N |
| LAB_DATA: | |
| V_ADMINBY: | PUB |
| OTHER_MEDS: | Humalog (fast acting insulin) for Type 1 Diabetes via pod. |
| CUR_ILL: | None known. |
| HISTORY: | Type 1 Diabetes for 5 years (2016) |
| PRIOR_VAX: | |
| SPLTTYPE: | |
| FORM_VERS: | |
| TODAYS_DATE: | 11-12-2021 |
| BIRTH_DEFECT: | U |
| OFC_VISIT: | U |
| ER_ED_VISIT: | U |
| ALLERGIES: | Amoxicillin sensitivity. |
| V_FUNDBY: |
Questions? Comments? Bugs?
[email protected]
Due to the high volume of inquiries, please be patient with response times.
AND PLEASE read the FAQ first.
OpenVAERS is a private organization that posts publicly available CDC/FDA data of injuries reported post-vaccination. Reports are not proof of causality.